Scientists publish criteria for memory disorder tied to tau accumulation | Vitamin B12, folic acid ineffective in protecting memory | Study connects long-term use of mobile phones to glioma risk
Web Version
November 14, 2014
CONNECT WITH SNMMI LinkedInFacebookTwitterYoutube
SNMMI SmartBrief
News for nuclear medicine and molecular imaging professionals

Top Story
Scientists publish criteria for memory disorder tied to tau accumulation
A study in the journal Acta Neuropathologica establishes criteria for diagnosing primary age-related tauopathy, or PART. The condition is characterized by the formation of neurofibrillary tau tangles and an absence of amyloid plaques. Patients with PART develop memory impairment similar to those with Alzheimer's disease that is severe in the oldest patients but often mild in elderly patients who are younger. release (11/13)
Share: LinkedInTwitterFacebookGoogle+Email
Clinical News & Research
Vitamin B12, folic acid ineffective in protecting memory
A study in the journal Neurology showed that folic acid and vitamin B12 supplements may not reduce the risk of memory loss in seniors. Researchers found no difference in performance on memory and thinking tests between patients who took vitamin B12 and folic acid for two years and those who took a placebo. HealthDay News (11/12)
Share: LinkedInTwitterFacebookGoogle+Email
Study connects long-term use of mobile phones to glioma risk
A study reported in Pathophysiology found long-term use of a mobile or cordless phone was associated with three times the risk of glioma, the most common type of brain tumor. Risk was also elevated among those who were younger than 20 years old when they first started using a mobile or cordless phone. One of the study's authors recommends precautions such using the speakerphone feature. Medscape (free registration) (11/13)
Share: LinkedInTwitterFacebookGoogle+Email
Industry Report
Shine pushes through funding challenges to address Mo-99 supply worries
Shine Medical Technologies has plans for a medical isotope production plant that will use low-enriched uranium technology to meet one-third of global demand for molybdenum-99 while also producing iodine-131 and xenon-133. A shortage of funding has delayed progress, according to Shine CEO Gregory Piefer, but Shine officials hope to benefit from implementation of the American Medical Isotopes Production Act, which will allocate $163 million to support domestic production of isotopes. (free registration) (11/14)
Share: LinkedInTwitterFacebookGoogle+Email
Siemens launches more compact SPECT device
Siemens Healthcare has upgraded its Symbia Evo Excel SPECT system, a multipurpose device that has a short tunnel length and scan length of up to 6 feet, 7 inches. It includes a larger bore size and flexible detectors. The new system accommodates patients up to 500 pounds and is designed to fit smaller rooms. (free registration) (11/13)
Share: LinkedInTwitterFacebookGoogle+Email
News from the Field
Telemedicine used by 33% of docs, poll shows
A survey by the Academy of Integrative Health & Medicine revealed 33% of responding physicians reported using some form of telemedicine, while 29% intend to do so soon. However, only 19% of respondents said they received reimbursement for such services. (11/13)
Share: LinkedInTwitterFacebookGoogle+Email
Health Policy
Republican move to repeal device tax expected
The GOP's Senate majority win during last week's elections means Sen. Orrin Hatch, R-Utah, will lead the Senate Finance Committee, and analysts and congressional aides said a move to repeal the 2.3% medical device tax is imminent. "The senator will continue to examine and support every viable opportunity to permanently repeal [the] onerous tax on medical devices," a spokeswoman for Hatch said. Reuters (11/12)
Share: LinkedInTwitterFacebookGoogle+Email
Grants and Funding
12 cancer researchers awarded portion of $15M in V Foundation grants
The Translational Grant Program of the V Foundation for Cancer Research has awarded part of $15 million in grants to 12 researchers studying the disease. Recipients will each receive $600,000 over three years. American City Business Journals/Raleigh/Durham, N.C. (11/11)
Share: LinkedInTwitterFacebookGoogle+Email
Advancing Health Care
Study: Dashboard flags high-risk drug regimens
A new platform designed by Vanderbilt University researchers flags potentially inappropriate medications given to older inpatients, according to a study in the Journal of the American Geriatrics Society. The computerized dashboard flagged potentially inappropriate medications for 22% of 797 patients over three weeks, and researchers concluded that the tool helped clinical pharmacists screen drug regimens. News (11/11)
Share: LinkedInTwitterFacebookGoogle+Email
New SNMMI member benefit -- free journal SAMs
SNMMI members now have free access to journal SAMs as a membership benefit to help meet Maintenance of Certification Part II Self Assessment program requirements. View journal SAMs.
Share: LinkedInTwitterFacebookGoogle+Email
Order the top-selling Quick Reference Protocol Manual for Nuclear Medicine Technologists
Grab your copy of this popular new book from SNMMI. Targeting technologists, the new Quick Reference Protocol Manual for Nuclear Medicine Technologists provides structured, up-to-date information for more than 70 nuclear medicine procedures. Each protocol lists the essential information for the procedure, from patient preparation through dose and administration. Learn more and order your copy today!
Share: LinkedInTwitterFacebookGoogle+Email
Editor's Note
A summary in SNMMI SmartBrief on Wednesday should have said Lantheus Medical Imaging postponed its plans for an initial public offering in July. The company has announced it would pursue the IPO.
Share: LinkedInTwitterFacebookGoogle+Email
In helping others, we shall help ourselves, for whatever good we give out completes the circle and comes back to us."
-- Flora Edwards,
American author
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about SNMMI ->SNMMI | News | Meetings | Education | Publications | Membership
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items above are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Editor:  Melissa Turner
Advertising:  Meryl Harold
  P: 202.407.7828

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information